Plasma metabolites related to cellular energy metabolism are altered in adults with Down syndrome and Alzheimer's disease
- 1 July 2019
- journal article
- research article
- Published by Wiley in Developmental Neurobiology
- Vol. 79 (7), 622-638
- https://doi.org/10.1002/dneu.22716
Abstract
Down syndrome (DS) is a well-known neurodevelopmental disorder most commonly caused by trisomy of chromosome 21. Because individuals with DS almost universally develop heavy amyloid burden and Alzheimer's disease (AD), biomarker discovery in this population may be extremely fruitful. Moreover, any AD biomarker in DS that does not directly involve amyloid pathology may be of high value for understanding broader mechanisms of AD generalizable to the neurotypical population. In this retrospective biomarker discovery study, we examined banked peripheral plasma samples from 78 individuals with DS who met clinical criteria for AD at the time of the blood draw (DS-AD) and 68 individuals with DS who did not (DS-NAD). We measured the relative abundance of approximately 5,000 putative features in the plasma using untargeted mass spectrometry (MS). We found significantly higher levels of a peak putatively annotated as lactic acid in the DS-AD group (q = .014), a finding confirmed using targeted MS (q = .011). Because lactate is the terminal product of glycolysis and subsequent lactic acid fermentation, we performed additional targeted MS focusing on central carbon metabolism which revealed significantly increased levels of pyruvic (q = .03) and methyladipic (q = .03) acids in addition to significantly lower levels of uridine (q = .007) in the DS-AD group. These data suggest that AD in DS is accompanied by a shift from aerobic respiration toward the less efficient fermentative metabolism and that bioenergetically derived metabolites observable in peripheral blood may be useful for detecting this shift.Keywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD065160)
- National Institute on Aging (AG016573, AG021912)
This publication has 102 references indexed in Scilit:
- Antioxidants in Down syndromeBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasisProceedings of the National Academy of Sciences of the United States of America, 2012
- Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like DementiaCurrent Gerontology and Geriatrics Research, 2011
- Down syndrome: searching for the genetic culpritsDisease Models & Mechanisms, 2011
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Capturing Heterogeneity in Gene Expression Studies by Surrogate Variable AnalysisPLoS Genetics, 2007
- Pyruvate protects mitochondria from oxidative stress in human neuroblastoma SK-N-SH cellsBrain Research, 2007
- Phytanic acid: production from phytol, its breakdown and role in human diseaseCellular and Molecular Life Sciences, 2006
- XCMS: Processing Mass Spectrometry Data for Metabolite Profiling Using Nonlinear Peak Alignment, Matching, and IdentificationAnalytical Chemistry, 2006
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991